The laboratory information management system (LIMS) landscape in 2024 is a dynamic one, driven by accelerating advancements in technology and evolving industry needs. This article shares the four key trends.
- What Proposed Plasmid DNA Standards Say For GMP/Non-GMP Production
- Drugging The Undruggable: Strategies And Future Directions
- 8 Key Takeaways Of The Proposed FDA Modernization Act 3.0
- Shocking! Biotech Facilities Don't Maintain Themselves
- The Future of Rare Diseases with The Jackson Laboratory’s Rare Disease Translational Center's Cat Lutz
- Exploring Biolistic Particle Delivery Systems
- Comparability Considerations For mRNA Product Development
- FDA’s Updated Guidance On Human Genome Editing: New Implications & Remaining Questions
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Data Utilization For Advanced Analytics And Near Real-Time Monitoring
Control, monitor, and analyze equipment, processes, results, and data in near real time and make data-driven decisions at both the process and plant levels.
-
Optimizing Process Loads For VHP Decontamination
Explore how CAI helped a company rescue a failing CQV project and create more efficient Vapourized Hydrogen Peroxide Material Air Lock (VHP MAL) Loads to enhance operational efficiency.
-
Optimizing Kinetics Assays To Avoid Avidity Effects
Considering affinity and avidity early in assay design can ensure the desired assay parameters are achieved. Learn about affinity and avidity and how to recognize and resolve issues that may arise.
-
Implementing High Cell Density Cryopreservation In Your Seed Train
Simplify seed train intensification with high cell density cryopreservation. Eliminate the need for manual scale-up steps and enable risk reduction through closed banking and inoculation processes.
-
Imaging-Based Ultra-High Content Phenotyping
Explore the results of a study where an imaging platform was applied to validate the tumor specificity of previously screened targets.
-
Dispensing Fungal Spores
Learn how this single cell dispenser was used to sort and isolate individual, fluorescently labeled germinating fungal spores among non-germinating spores.
-
Reliable, Hands-Free, And High-Throughput Cell Viability Assays
To validate the importance of using an automated PI staining process with a MACSQuant® Flow Cytometer, we processed various 96-well plates of Jurkat cells under different conditions.
-
A Tool For Measuring Liquid Mixing Efficacy In Verification Plates
For trustworthy assay results, the methodology employed must be assessed. Learn how a multichannel verification system can be used as a tool for measuring the efficacy of liquid mixing protocols.
-
Trends In The Outsourcing Of Development And Manufacturing Of Biologics
Read more on trends related to outsourcing and share what attributes of an outsourcing partner are sought by developers and manufacturers of biopharmaceuticals.
-
Primary Clarification Of CHO Cells With Single-Use Centrifuge Tech
Learn about a single-use cell harvesting system designed for primary clarification of mammalian cell cultures and harvesting along with how the system performs in a cell culture clarification process.
NEWSLETTER ARCHIVE
- 03.18.24 -- Bringing Therapies To Patients With Speed And Confidence
- 03.18.24 -- Reducing Batch-To-Batch Variation In Cell Therapy Manufacturing
- 03.14.24 -- Explore Revolutionary Research Shaping Medicine
- 03.14.24 -- mRNA: Challenges & Opportunities For Scale-Out, Optimization
- 03.13.24 -- Regulatory & GMP Manufacturing Insights Into mRNA-LNP Drug Products
- Rare Disease Day 2024
- Video Clips From Cell & Gene Live: 2024 Regulatory Outlook With FDA's Dr. Peter Marks And Dr. Nicole Verdun
- Inside Cell & Gene Live “How To Reduce Batch-To-Batch Variation In Cell Therapy Manufacturing”
- Mass General Cancer Center’s Dr. Genevieve Boland on Amtagvi Approval
- Inside Cell & Gene Live “2024 Regulatory Outlook With FDA’s Dr. Peter Marks And Dr. Nicole Verdun”
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections